Table 1 List of specific objectives, mapped onto different parts of the study
No. | Objectives |
|---|---|
Part 1 — Testing cognitive screening pathway | |
1. | Explore how the NEuRoMS cognitive screening and management pathway is integrated within routine clinical practice |
2. | Refine the cognitive screening pathway by evaluating online cognitive screening and usage data and the observations of clinicians/intervention providers |
3. | Assess suitability of online cognitive screening tool for capturing cognitive deficits |
4. | Assess the frequency and extent of no, mild, and moderate-severe cognitive deficits and, thus, the size of the target population (potentially eligible participants for a future definitive RCT) based on online cognitive screening tool |
Part 2 — Acceptability, feasibility RCT, and fidelity evaluation | |
1. | Identify the necessary parameters and tools to undertake a clinical and cost-effectiveness analysis in a future definitive trial |
2. | Assess acceptability of data collection tools, processes, data completeness, and follow-up rates and determine suitability of outcome measures |
3. | Identify factors that may affect running of the definitive trial, including barriers and facilitators to recruitment, retention, and delivery of the intervention |
4. | Evaluate the feasibility and acceptability of the NEuRoMS intervention |
5. | Evaluate and optimise intervention usage and acceptability |
6. | Explore ways to assess (type and extent) and minimise contamination |
7. | Develop and assess intervention fidelity tools |
8. | Develop a framework for cost-effectiveness analyses |
9. | Characterise ‘usual care’ in the different sites |
Part 3 — Exploring stakeholder views and experiences | |
1. | Gather detailed qualitative feedback interviews on the pathway, intervention, and study procedures to assess their feasibility and acceptability |
2. | Understand the barriers, facilitators, and broader context for delivering and receiving screening and management pathway |
3. | Improve understanding of how the NEuRoMS screening and management pathway is integrated within routine clinical practice |
4. | Improve understanding of how the NEuRoMS intervention programme is experienced by those who deliver and receive it |
5. | Evaluate and refine staff training package for cognitive screening and management pathway |
6. | Refine the programme theory (and logic model) for the newly developed screening pathway and NEuRoMS intervention programme, embedding it in clinical practice |